BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9425876)

  • 21. Patient perception of generic antiepileptic drugs in the Midwestern United States.
    Papsdorf TB; Ablah E; Ram S; Sadler T; Liow K
    Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.
    Pugh CB; Garnett WR; Poynor WJ; Pellock JM
    Clin Pharm; 1984; 3(6):643-9. PubMed ID: 6439455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and cost of generic versus brand-name valproic acid.
    Coulter DL
    Ment Retard; 1997 Dec; 35(6):472-5. PubMed ID: 9425877
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of valproic acid on blood loss in patients with cerebral palsy.
    Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
    J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of seizures and antiepileptic drugs on prolactin secretions.
    Wang MF
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):742-4. PubMed ID: 12376268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptic drug status in adult outpatients with mental retardation.
    Singh BK; Towle PO
    Am J Ment Retard; 1993; 98 Suppl():41-6. PubMed ID: 8352921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical challenge of a complex population: seizures, anticonvulsants, mental retardation, and institutions.
    Rubin L
    Am J Ment Retard; 1989 May; 93(6):603-4. PubMed ID: 2719842
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug interactions between chemotherapeutic regimens and antiepileptics.
    Yap KY; Chui WK; Chan A
    Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproic acid as the AED of choice for patients with glioblastoma? The jury is out.
    Wen PY; Schiff D
    Neurology; 2011 Sep; 77(12):1114-5. PubMed ID: 21880995
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of valproic acid in HIV-positive patients.
    Jennings HR; Romanelli F
    Ann Pharmacother; 1999 Oct; 33(10):1113-6. PubMed ID: 10534224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in anticonvulsant management of childhood seizure disorders.
    Woody RC
    J Ark Med Soc; 1984 Feb; 80(9):404-7. PubMed ID: 6233256
    [No Abstract]   [Full Text] [Related]  

  • 36. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible dementia and gait disturbance after prolonged use of valproic acid.
    Evans MD; Shinar R; Yaari R
    Seizure; 2011 Jul; 20(6):509-11. PubMed ID: 21435910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety of rapid valproic acid infusion.
    Limdi NA; Faught E
    Epilepsia; 2000 Oct; 41(10):1342-5. PubMed ID: 11051132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product.
    MacDonald JT
    Neurology; 1987 Dec; 37(12):1885. PubMed ID: 3120036
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of generic valparin xr in the treatment of epilepsy.].
    Gromov SA; Lipatova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):44-6. PubMed ID: 18477978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.